{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:27:31Z","timestamp":1783038451024,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-018-0283-7","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T15:28:33Z","timestamp":1542036513000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions"],"prefix":"10.1038","volume":"4","author":[{"given":"Leslie","family":"Goo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Debbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurgun","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Sapparapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex W.","family":"Wessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Richner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Burgomaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget C.","family":"Larman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-1079","authenticated-orcid":false,"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-4348","authenticated-orcid":false,"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"283_CR1","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4269\/ajtmh.2008.79.974","volume":"79","author":"CA Reimann","year":"2008","unstructured":"Reimann, C. A. et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999\u20132007. Am. J. Trop. Med. Hyg. 79, 974\u2013979 (2008).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"283_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.15252\/embr.201745302","volume":"19","author":"FA Rey","year":"2018","unstructured":"Rey, F. A., Stiasny, K., Vaney, M. C., Dellarole, M. & Heinz, F. X. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Rep. 19, 206\u2013224 (2018).","journal-title":"EMBO Rep."},{"key":"283_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1128\/MMBR.00024-15","volume":"80","author":"LA VanBlargan","year":"2016","unstructured":"VanBlargan, L. A., Goo, L. & Pierson, T. C. Deconstructing the antiviral neutralizing-antibody response: implications for vaccine development and immunity. Microbiol. Mol. Biol. Rev. 80, 989\u20131010 (2016).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"283_CR4","doi-asserted-by":"publisher","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","volume":"4","author":"S Nelson","year":"2008","unstructured":"Nelson, S. et al. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog. 4, e1000060 (2008).","journal-title":"PLoS Pathog."},{"key":"283_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","volume":"2","author":"TC Pierson","year":"2012","unstructured":"Pierson, T. C. & Diamond, M. S. Degrees of maturity: the complex structure and biology of flaviviruses. Curr. Opin. Virol. 2, 168\u2013175 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"283_CR6","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/emboj.2009.245","volume":"28","author":"MV Cherrier","year":"2009","unstructured":"Cherrier, M. V. et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 28, 3269\u20133276 (2009).","journal-title":"EMBO J."},{"key":"283_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0042-6822(92)90267-S","volume":"191","author":"F Guirakhoo","year":"1992","unstructured":"Guirakhoo, F., Bolin, R. A. & Roehrig, J. T. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 191, 921\u2013931 (1992).","journal-title":"Virology"},{"key":"283_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/viro.1994.1013","volume":"198","author":"FX Heinz","year":"1994","unstructured":"Heinz, F. X. et al. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198, 109\u2013117 (1994).","journal-title":"Virology"},{"key":"283_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant, T. et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11, 522\u2013530 (2005).","journal-title":"Nat. Med."},{"key":"283_CR10","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1128\/JVI.00551-06","volume":"80","author":"M Throsby","year":"2006","unstructured":"Throsby, M. et al. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile virus. J. Virol. 80, 6982\u20136992 (2006).","journal-title":"J. Virol."},{"key":"283_CR11","doi-asserted-by":"publisher","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","volume":"79","author":"LH Gould","year":"2005","unstructured":"Gould, L. H. et al. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J. Virol. 79, 14606\u201314613 (2005).","journal-title":"J. Virol."},{"key":"283_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","volume":"1","author":"TC Pierson","year":"2007","unstructured":"Pierson, T. C. et al. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1, 135\u2013145 (2007).","journal-title":"Cell Host Microbe"},{"key":"283_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nature03956","volume":"437","author":"GE Nybakken","year":"2005","unstructured":"Nybakken, G. E. et al. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437, 764\u2013769 (2005).","journal-title":"Nature"},{"key":"283_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1001\/jama.2013.8267","volume":"310","author":"WM Chung","year":"2013","unstructured":"Chung, W. M. et al. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 310, 297\u2013307 (2013).","journal-title":"JAMA"},{"key":"283_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","volume":"346","author":"TC Pierson","year":"2006","unstructured":"Pierson, T. C. et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346, 53\u201365 (2006).","journal-title":"Virology"},{"key":"283_CR16","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","volume":"319","author":"L Li","year":"2008","unstructured":"Li, L. et al. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319, 1830\u20131834 (2008).","journal-title":"Science"},{"key":"283_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"283_CR18","doi-asserted-by":"publisher","first-page":"18950","DOI":"10.1073\/pnas.1011036107","volume":"107","author":"B Kaufmann","year":"2010","unstructured":"Kaufmann, B. et al. Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proc. Natl Acad. Sci. USA 107, 18950\u201318955 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"283_CR19","doi-asserted-by":"publisher","first-page":"139ra183","DOI":"10.1126\/scitranslmed.3003888","volume":"4","author":"EP Teoh","year":"2012","unstructured":"Teoh, E. P. et al. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl Med. 4, 139ra183 (2012).","journal-title":"Sci. Transl Med."},{"key":"283_CR20","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R de Alwis","year":"2012","unstructured":"de Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl Acad. Sci. USA 109, 7439\u20137444 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"283_CR21","doi-asserted-by":"publisher","first-page":"D482","DOI":"10.1093\/nar\/gkw1065","volume":"45","author":"EL Hatcher","year":"2017","unstructured":"Hatcher, E. L. et al. Virus Variation Resource\u2014improved response to emergent viral outbreaks. Nucleic Acids Res. 45, D482\u2013D490 (2017).","journal-title":"Nucleic Acids Res."},{"key":"283_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jim.2008.04.008","volume":"336","author":"X Yu","year":"2008","unstructured":"Yu, X., McGraw, P. A., House, F. S. & Crowe, J. E. Jr. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods 336, 142\u2013151 (2008).","journal-title":"J. Immunol. Methods"},{"key":"283_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/JVI.80.3.1290-1301.2006","volume":"80","author":"CW Davis","year":"2006","unstructured":"Davis, C. W. et al. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 80, 1290\u20131301 (2006).","journal-title":"J. Virol."},{"key":"283_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.virol.2008.08.021","volume":"381","author":"C Ansarah-Sobrinho","year":"2008","unstructured":"Ansarah-Sobrinho, C., Nelson, S., Jost, C. A., Whitehead, S. S. & Pierson, T. C. Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology 381, 67\u201374 (2008).","journal-title":"Virology"},{"key":"283_CR25","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","volume":"16","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep. 16, 1485\u20131491 (2016).","journal-title":"Cell Rep."},{"key":"283_CR26","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1128\/JVI.06435-11","volume":"86","author":"TY Lin","year":"2012","unstructured":"Lin, T. Y. et al. A novel approach for the rapid mutagenesis and directed evolution of the structural genes of West Nile virus. J. Virol. 86, 3501\u20133512 (2012).","journal-title":"J. Virol."},{"key":"283_CR27","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1128\/JVI.00643-07","volume":"81","author":"T Oliphant","year":"2007","unstructured":"Oliphant, T. et al. Induction of epitope-specific neutralizing antibodies against West Nile virus. J. Virol. 81, 11828\u201311839 (2007).","journal-title":"J. Virol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-018-0283-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-018-0283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-018-0283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:53:06Z","timestamp":1671249186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-018-0283-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1038\/s41564-018-0283-7","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"30 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.D. is a consultant for Inbios and Sanofi-Pasteur and is on the Scientific Advisory Board of Moderna. J.E.C. has served as a consultant for Takeda Vaccines, Sanofi Pasteur, Pfizer and Novavax; is on the Scientific Advisory Boards of CompuVax, GigaGen, Meissa Vaccines and PaxVax; and is Founder of IDBiologics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}